Pesić V, Kosec D, Radojević K, Pilipović I, Perisić M, Vidić-Danković B, Leposavić G
Department of Physiology, Faculty of Pharmacy, University of Belgrade, 11221 Belgrade, Serbia.
J Neuroimmunol. 2009 Sep 29;214(1-2):55-66. doi: 10.1016/j.jneuroim.2009.06.018. Epub 2009 Jul 30.
The study was undertaken to explore: i) the presence of alpha(1)-adrenoceptors (AR) on thymic lymphoid and non-lymphoid cells and ii) their putative role in T-cell development. The expression of alpha(1)-AR on thymic cells was assessed using both immunohistochemistry and flow cytometric analyses, while their putative role in thymopoiesis was estimated by analyses of thymocyte proliferation and apoptosis, and major thymocyte subset distribution in adult rats subjected to 14-day-long treatment with the alpha(1)-AR blocker urapidil. The presence of alpha(1)-AR was demonstrated on both thymocytes (mainly less mature CD3(-) and CD3(low) cells) and thymic non-lymphoid cells (thymic epithelial cells and CD68-positive cells). Chronic treatment with urapidil increased the thymic weight and thymocyte number. The increase in thymocyte number might, at least partly, be related to an enhanced thymocyte proliferation. In addition, an altered thymocyte subset distribution was observed in these rats. The increase in the percentage of CD4+CD8+ double positive (DP) TCRalphabeta(-) thymocytes was accompanied by the reduction in that of CD4+CD8+ (DP) TCRalphabeta(low) cells, and divergent changes in the percentage of the most mature single positive (SP) TCRalphabeta(high) thymocytes. In urapidil-administered rats the percentage of CD4+CD8- SP TCRalphabeta(high) thymocytes was increased, while that of the CD4-CD8+ TCRalphabeta(high) was reduced, compared with controls. In addition, proportions of CD4+CD25+RT6.1- and CD161+TCRalphabeta+ regulatory cells were increased. Collectively, the results indicate that alpha(1)-AR are involved in complex network of neuro-thymic and intrathymic communications that provide fine tuning of both conventional effector and regulatory T-cell development.
i)胸腺淋巴细胞和非淋巴细胞上α(1)-肾上腺素能受体(AR)的存在情况;ii)它们在T细胞发育中的假定作用。采用免疫组织化学和流式细胞术分析评估胸腺细胞上α(1)-AR的表达,而通过分析胸腺细胞增殖和凋亡以及成年大鼠经α(1)-AR阻滞剂乌拉地尔14天长期治疗后主要胸腺细胞亚群分布来评估它们在胸腺生成中的假定作用。在胸腺细胞(主要是成熟度较低的CD3(-)和CD3(低)细胞)和胸腺非淋巴细胞(胸腺上皮细胞和CD68阳性细胞)上均证实存在α(1)-AR。乌拉地尔长期治疗可增加胸腺重量和胸腺细胞数量。胸腺细胞数量的增加可能至少部分与胸腺细胞增殖增强有关。此外,在这些大鼠中观察到胸腺细胞亚群分布发生改变。CD4 + CD8 +双阳性(DP)TCRαβ(-)胸腺细胞百分比增加,同时CD4 + CD8 +(DP)TCRαβ(低)细胞百分比降低,最成熟的单阳性(SP)TCRαβ(高)胸腺细胞百分比发生不同变化。与对照组相比,给予乌拉地尔的大鼠中CD4 + CD8 - SP TCRαβ(高)胸腺细胞百分比增加,而CD(4)-CD8 + TCRαβ(高)胸腺细胞百分比降低。此外,CD4 + CD25 + RT6.1 -和CD161 + TCRαβ +调节性细胞的比例增加。总体而言,结果表明α(1)-AR参与神经-胸腺和胸腺内通讯的复杂网络,该网络对传统效应性T细胞和调节性T细胞的发育进行微调。